Quick Answer
Niagen Bioscience, Inc. reported Net Income of $17.38 million for fiscal year 2025.
Niagen Bioscience, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $17.38M | +103.3% |
| 2024 | $8.55M | +273.1% |
| 2023 | -$4.94M | +70.1% |
| 2022 | -$16.54M | +39.0% |
| 2021 | -$27.13M | -36.2% |
| 2020 | -$19.93M | +38.0% |
| 2019 | -$32.15M | +3.5% |
| 2018 | -$33.32M | -192.8% |
| 2017 | -$11.38M | -288.6% |
| 2016 | -$2.93M | -5.7% |
| 2015 | -$2.77M | +48.6% |
| 2014 | -$5.39M | -21.9% |
| 2013 | -$4.42M | +62.1% |
| 2012 | -$11.66M | -47.7% |
| 2011 | -$7.89M | -284.8% |
| 2010 | -$2.05M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.58M | +143.8% | +26.8% |
| June 30, 2025 | $3.61M | +24160.0% | -28.7% |
| March 31, 2025 | $5.06M | +1129.1% | +169.6% |
| September 30, 2024 | $1.88M | +295.8% | +12620.0% |
| June 30, 2024 | -$15.0K | +99.3% | +97.0% |
| March 31, 2024 | -$492.0K | +74.1% | +48.7% |
| September 30, 2023 | -$959.0K | +2.6% | +56.2% |
| June 30, 2023 | -$2.19M | +65.7% | -15.2% |
- Niagen Bioscience, Inc. showed an increase of +103.3% in Net Income compared to the prior fiscal year.
- Over the 2010–2025 period, Niagen Bioscience, Inc.’s net income has grown by 947.2% (from -$2.05 million to $17.38 million).
- The most recent figure is from Niagen Bioscience, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: